Key facts
- TiumBio announced clinical trial data for its head and neck cancer drug.
- The company will proceed to the next stage of development.
TiumBio is a biopharmaceutical company focused on developing new treatments. This announcement pertains to the progress of one of its drug candidates in clinical trials for head and neck cancer.